HCIA Complex/High-Risk Patient Targeting: Third Annual .
THIRD ANNUAL REPORT ADDENDUMHCIA Complex/High-Risk Patient Targeting:Third Annual Report AddendumAPRIL 7, 2017PRESENTED TO:Katherine GiuriceoCMMI7500 Security BoulevardBaltimore, MD 21244PRESENTED BY:Roy AhnNORC at the University of Chicago4350 East-West Hwy, Suite 800Bethesda, MD 20814312-759-4068
NORC HCIA Complex/High-Risk Patient TargetingTable of ContentsExecutive Summary . 1Introduction and Methods . 17Evaluation Design . 20Quantitative Methods (Claims Based Analyses) . 22Qualitative and Survey Methods . 25Rapid Cycle Evaluation: Revising Issues of Feasibility and Evaluability . 25Awardee-Level Analyses: Overview . 27California Long-Term Care Education Center . 30Courage Kenny Rehabilitation Institute . 38Developmental Disabilities Health Services . 46Johns Hopkins University Community Health Partnership . 50Johns Hopkins University School of Nursing . 76LifeLong Medical Care . 87Northland Healthcare Alliance . 93Palliative Care Consultants of Santa Barbara . 98Pittsburgh Regional Health Initiative . 105Providence Portland Medical Center . 115St. Francis Healthcare Foundation of Hawaii . 139Sutter Health Corporation . 151University Emergency Medical Services . 157University of New Mexico . 164University of North Texas . 170TECHNICAL APPENDICES . 174Appendix A: Awardee and Intervention Names and Abbreviations . 175Appendix B: Definition of Acronyms . 176ADDENDUM TO THE THIRD ANNUAL REPORT II
NORC HCIA Complex/High-Risk Patient TargetingAppendix C: Methods, Claims-based Analyses . 178Appendix D: Claims-based Analyses: Supporting Exhibits . 182California Long-Term Care Education Center . 185Courage Kenny Rehabilitation Center . 186Developmental Disabilities Health System . 188Johns Hopkins Community Health Partnership . 190Johns Hopkins University School of Nursing . 202LifeLong Medical Care . 205Northland Healthcare Alliance . 207Palliative Care Consultants of Santa Barbara . 209Pittsburgh Regional Health Initiative . 210Providence Portland Medical Center . 213St. Francis Healthcare Foundation of Hawaii . 233Sutter Health Corporation . 237University Emergency Medical Services. 238University of New Mexico . 240University of North Texas . 242Appendix E: List of Evaluation Questions . 246ADDENDUM TO THE THIRD ANNUAL REPORT III
NORC HCIA Complex/High-Risk Patient TargetingList of ExhibitsExhibit ES.1:Health Care Innovation Awardees, Complex/High-Risk PatientTargeting . 2Exhibit ES.2:Conceptual Framework, Evaluation of the CHRPT Portfolio of HCIAAwardees . 3Exhibit ES.3:Cost Effects Associated with HCIA One Interventions, by Awardee . 8Exhibit ES.4:Average Quarterly Total Cost of Care for Awardees with StatisticallySignificant Findings, by Awardee . 9Exhibit ES.5:Aggregate Total Cost of Care for Awardees with StatisticallySignificant Findings, by Awardee . 10Exhibit ES.6:Effects on Hospitalizations and ED Visits Associated with HCIA OneInterventions, by Awardee . 13Exhibit ES.7:Effects on Readmissions and Quality of Care Associated with HCIAOne Interventions, by Awardee . 14Exhibit 1.1:The Complex/High-Risk Patient Targeting Awardees . 19Exhibit 1.2:Conceptual Framework, Evaluation of the CHRPT Portfolio of HCIAAwardees . 21Exhibit 1.3:Data Source and Evaluation Design for Addendum, by Awardee . 23Exhibit 1.4:Claims-Based Measures of Program Effectiveness, by Awardee . 24Exhibit 1.5:Challenges to Evaluability: Representativeness of Claims Data,By Awardee . 26Exhibit 2.1:Program Effectiveness: A Visual Guide . 27Exhibit 2.2:Summary, Awardee Chapter Contents for NORC No-Cost ExtensionAddendum . 28Exhibit CLTCEC.1:Descriptive Characteristics for CLTCEC Program Participants andComparison Participants . 32Exhibit CLTCEC.2:Impact of the CLTCEC Program on Outcomes . 34Exhibit CLTCEC.3:Impact of CLTCEC Program on Outcomes, by Quarter . 35Exhibit CLTCEC.4:Impact of CLTCEC Program on Outcomes, Second Year afterProgram Enrollment . 36Exhibit CKRI.1:Descriptive Characteristics for CKRI and Comparison GroupMedicare Beneficiaries . 40Exhibit CKRI.2:Impact of CKRI Program on Outcomes for Medicare Beneficiaries . 41Exhibit CKRI.3:Impact of CKRI Program on Outcomes for Medicare Beneficiaries,by Quarter . 42Exhibit CKRI.4:Descriptive Characteristics for CKRI and Comparison GroupMedicaid Beneficiaries . 44Exhibit CKRI.5:Impact of CKRI Program on Outcomes for Medicaid Beneficiaries . 45ADDENDUM TO THE THIRD ANNUAL REPORT IV
NORC HCIA Complex/High-Risk Patient TargetingExhibit DDHS.1:Descriptive Characteristics for DD Health Home and ComparisonGroup Beneficiaries . 48Exhibit DDHS.2:Impact of the DD Health Home Program on Outcomes . 49Exhibit J-CHiP.1:Impact of the J-CHiP Hospital Arm on Medicare Outcomes . 55Exhibit J-CHiP.2:Impact of the J-CHiP Hospital Arm by Quarter, Medicare . 56Exhibit J-CHiP.3:Descriptive Characteristics for the J-CHiP Hospital Arm andComparison Group Beneficiary-Episodes, Medicaid . 58Exhibit J-CHiP.4:Impact of the J-CHiP Hospital Arm on Outcomes, Medicaid . 60Exhibit J-CHiP.5:Descriptive Characteristics for the J-CHiP Community Arm andComparison Group Beneficiaries, Medicare. 63Exhibit J-CHiP.6:Impact of the J-CHiP Community Arm on Outcomes, Medicare . 64Exhibit J-CHiP.7:Impact of the J-CHiP Community Arm by Quarter, Medicare . 65Exhibit J-CHiP.8:Descriptive Characteristics for J-CHiP Community Arm andComparison Group Beneficiaries, Medicaid . 67Exhibit J-CHiP.9:Impact of the J-CHiP Intervention’s Community Arm, MedicaidBeneficiaries . 69Exhibit JHUSON.1:Descriptive Characteristics for Project CAPABLE and ComparisonGroup Medicare Beneficiaries . 79Exhibit JHUSON.2:Impact of the Project CAPABLE Program on Outcomes for MedicareBeneficiaries . 80Exhibit JHUSON.3:Impact of the Project CAPABLE Program on Outcomes for MedicareBeneficiaries, by Quarter . 82Exhibit JHUSON.4:Descriptive Characteristics for Project CAPABLE and ComparisonGroup Medicaid Beneficiaries . 84Exhibit JHUSON.5:Impact of the Project CAPABLE Program on Outcomes for MedicaidBeneficiaries . 85Exhibit JHUSON.6:Impact of the Project CAPABLE Program on Outcomes for MedicaidBeneficiaries, by Quarter . 86Exhibit LCCI.1:Descriptive Characteristics for LCCI and Comparison GroupBeneficiaries . 89Exhibit LCCI.2:Impact of the LCCI Program on Outcomes . 90Exhibit LCCI.3:Impact of the LCCI Program, by Quarter. 92Exhibit NCCS.1:Descriptive Characteristics for NCCS Program and ComparisonGroup Beneficiaries . 95Exhibit NCCS.2:Impact of the NCCS Program on Outcomes . 97Exhibit PCCSB.1:Descriptive Characteristics for DASH and Comparison GroupBeneficiaries . 100Exhibit PCCSB.2:Impact of the DASH Program on Outcomes . 101Exhibit PCCSB.3:Impact of the DASH Program by Quarter . 103Exhibit PRHI.1:Descriptive Characteristics for PCRC and Comparison GroupBeneficiary-Episodes. 108ADDENDUM TO THE THIRD ANNUAL REPORT V
NORC HCIA Complex/High-Risk Patient TargetingExhibit PRHI.2:Impact of PCRC Program on Outcomes . 110Exhibit PRHI.3:Impact of PCRC Program on Patients with Acute MyocardialInfarction. 111Exhibit PRHI.4:Impact of the PCRC Program on Patients with Congestive HeartFailure . 112Exhibit PRHI.5:Impact of the PCRC Program on Patients with Chronic ObstructivePulmonary Disease . 113Exhibit PPMC.1:Claims-based Findings for PPMC Programs . 117Exhibit PPMC.2:Descriptive Characteristics for PPMC HRP and Comparison GroupBeneficiaries . 120Exhibit PPMC.3:Impact of PPMC HRP on Outcomes . 121Exhibit PPMC.4:Descriptive Characteristics for New Directions Program andComparison Group Beneficiaries . 123Exhibit PPMC.5:Impact of New Directions Program on Outcomes . 124Exhibit PPMC.6:Descriptive Characteristics for PPMC ED Guides Program andComparison Group Beneficiaries . 126Exhibit PPMC.7:Impact of PPMC ED Guides Program on Outcomes . 127Exhibit PPMC.8:Descriptive Characteristics for PPMC Standard TransitionsProgram and Comparison Group Beneficiaries. 129Exhibit PPMC.9:Impact of PPMC Standard Transitions Program on Outcomes . 130Exhibit PPMC.10:Descriptive Characteristics for PPMC C-TRAIN and ComparisonGroup Beneficiaries . 132Exhibit PPMC.11:Impact of PPMC C-TRAIN Program on Outcomes . 133Exhibit PPMC.12:Descriptive Characteristics for PPMC ITT and Comparison GroupBeneficiaries . 135Exhibit PPMC.13:Impact of PPMC ITT Program on Outcomes . 136Exhibit HOPE.1:Descriptive Characteristics for the H.O.P.E. and ComparisonGroup Beneficiary-Episodes, Hospital Arm . 141Exhibit HOPE.2:Impact of the H.O.P.E. Program on Outcomes, Hospital Arm . 143Exhibit HOPE.3:Impact of the H.O.P.E. Program by Quarter, Hospital Arm . 145Exhibit HOPE.4:Descriptive Characteristics for H.O.P.E. and Comparison GroupBeneficiaries, Community Arm . 147Exhibit HOPE.5:Impact of the H.O.P.E. Program on Outcomes, Community Arm . 148Exhibit HOPE.6:Impact of the H.O.P.E. Program by Quarter, Community Arm . 149Exhibit AIM.1:Descriptive Characteristics for AIM and Comparison GroupBeneficiaries, End-of-Life Analysis . 154Exhibit AIM.2:Impact of the AIM Program on Outcomes . 155Exhibit AIM.3:AIM and Comparison Group Beneficiaries with MDS AssessmentData . 156ADDENDUM TO THE THIRD ANNUAL REPORT VI
NORC HCIA Complex/High-Risk Patient TargetingExhibit UEMS.1:Descriptive Characteristics for HEALTHIER and ComparisonGroup Beneficiaries . 160Exhibit UEMS.2:Impact of the HealthiER Program on Outcomes . 161Exhibit UEMS.3:Impact of the HealthiER Intervention by Quarter . 162Exhibit ECHO.1:Descriptive Characteristics for ECHO Care and ComparisonGroup Beneficiaries . 166Exhibit ECHO.2:Impact of the ECHO Care Program on Outcomes . 167Exhibit ECHO.3:Impact of the ECHO Care Program by Quarter . 168Exhibit BSLTOC.1:Impact of the BSLTOC Program on UTIs and Falls . 172Exhibit C.1:Types of Analyses for Claims-Based Measures in NORCAddendum Report . 179Exhibit C.2:Status of Medicaid Data Sources . 180Exhibit C.3:Supplemental Measures for Post-Acute Care Awardees . 181Exhibit D.1:Analyses that Include Common Support and Covariance BalanceCharts by Awardee . 183Exhibit D.2:Analyses that Include Quarterly Fixed Effects Charts of the Impactof HCIA-Funded Innovations on Outcomes by Quarter by Awardee . 184Exhibit D.CLTCEC.1: Test of Common Support and Covariate Balance, CLTCEC Program 185Exhibit D.CKRI.1:Test of Common Support and Covariate Balance, Medicare . 186Exhibit D.CKRI.2:Test of Common Support and Covariate Balance, Medicaid . 186Exhibit D.CKRI.3:Impact of the CKRI Program on Outcomes for MedicaidBeneficiaries, by Quarter . 187Exhibit D.DDHS.1:Test of Common Support and Covariate Balance, DD Health Home . 188Exhibit D.DDHS.2:Impact of the DD Health Home Program by Quarter. 189Exhibit D.J-CHiP.1:Common Support and Covariate Balance for J-CHiP and ComparisonBeneficiary-Episodes, Medicare . 190Exhibit D.J-CHiP.2:Common Support and Covariate Balance for Dually Eligible J-CHiPand Comparison Beneficiary-Episodes, Medicaid Analysis . 191Exhibit D.J-CHiP.3:Common Support and Covariate Balance for Medicaid Only J-CHiPand Comparison Beneficiary-Episodes, Medicaid Analysis . 192Exhibit D.J-CHiP.4:Impact of the J-CHiP Hospital Arm on Outcomes by Quarter,Medicaid . 193Exhibit D.J-CHiP.5:Common Support and Covariate Balance for J-CHiP andComparison Participants, Medicare . 194Exhibit D.J-CHiP.6:Impact of the J-CHiP Community Arm on Medicare Outcomes byQuarter . 195Exhibit D.J-CHiP.7:Common Support and Covariate Balance for Dually Eligible andComparison Participants, Medicaid Analysis . 196Exhibit D.J-CHiP.8:Common Support and Covariate Balance for Medicaid Only andComparison Participants, Medicaid Analysis . 196ADDENDUM TO THE THIRD ANNUAL REPORT VII
NORC HCIA Complex/High-Risk Patient TargetingExhibit
Exhibit LCCI.2: Impact of the LCCI Program on Outcomes . 90. Exhibit LCCI.3: Impact of the LCCI Program, by Quarter. 92. Exhibit N
Risk Matrix 15 Risk Assessment Feature 32 Customize the Risk Matrix 34 Chapter 5: Reference 43 General Reference 44 Family Field Descriptions 60 ii Risk Matrix. Chapter 1: Overview1. Overview of the Risk Matrix Module2. Chapter 2: Risk and Risk Assessment3. About Risk and Risk Assessment4. Specify Risk Values to Determine an Overall Risk Rank5
Risk is the effect of uncertainty on objectives (e.g. the objectives of an event). Risk management Risk management is the process of identifying hazards and controlling risks. The risk management process involves four main steps: 1. risk assessment; 2. risk control and risk rating; 3. risk transfer; and 4. risk review. Risk assessment
81. Risk Identification, page 29 82. Risk Indicator*, page 30 83. Risk Management Ω, pages 30 84. Risk Management Alternatives Development, page 30 85. Risk Management Cycle, page 30 86. Risk Management Methodology Ω, page 30 87. Risk Management Plan, page 30 88. Risk Management Strategy, pages 31 89. Risk
1.5 Tactical Risk Decisions and Crisis Management 16 1.5.1 Risk preparation 17 1.5.2 Risk discovery 17 1.5.3 Risk recovery 18 1.6 Strategic Risk Mitigation 19 1.6.1 The value-maximizing level of risk mitigation (risk-neutral) 19 1.6.2 Strategic risk-return trade-o s for risk-averse managers 20 1.6.3 P
Depositary Receipts (ADRs, EDRs and GDRs) Derivatives XX X Hedging XX X Speculation XX X Risk Factors in Derivatives XX X Correlation Risk X X X Counterparty Risk X X X Credit Risk XX X Currency Risk Illiquidity Risk X X X Leverage Risk X X X Market Risk X X X Valuation Risk X X X Volatility Risk X X X Futures XX X Swap Agreements XX X
Risk analysis Process to comprehend the nature of risk and to determine the level of risk Risk appetite Amount and type of risk that the organization is prepared to take in order to achieve its objectives. Risk assessment Overall process of risk identification , risk analysis and risk eva
The potential benefits of digital risk initiatives include efficiency and productivity gains, enhanced risk effectiveness, and revenue gains. The benefits of Exhibit 1 Digital risk management can significantly reduce losses and fines in core risk areas. Risk 2017 Digital Risk Exhibit 1 of 3 Credit risk Risk areas osses 2015, billion
An Introduction to Random Field Theory Matthew Brett , Will Penny †and Stefan Kiebel MRC Cognition and Brain Sciences Unit, Cambridge UK; † Functional Imaging Laboratory, Institute of Neurology, London, UK. March 4, 2003 1 Introduction This chapter is an introduction to the multiple comparison problem in func-
